Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

por Dillman, Robert O, Cornforth, Andrew N, McClay, Edward F, Depriest, Carol
Publicado 2019

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

por Dillman, Robert O., Cornforth, Andrew N., Nistor, Gabriel I., McClay, Edward F., Amatruda, Thomas T., Depriest, Carol
Publicado 2018

Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at...

por Dillman, Robert O., McClay, Edward F., Barth, Neil M., Amatruda, Thomas T., Schwartzberg, Lee S., Mahdavi, Khosrow, de Leon, Cristina, Ellis, Robin E., DePriest, Carol
Publicado 2015

Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study

por Verschraegen, Claire F, Jerusalem, Guy, McClay, Edward F, Iannotti, Nicholas, Redfern, Charles H, Bennouna, Jaafar, Chen, Franklin L, Kelly, Karen, Mehnert, Janice, Morris, John C, Taylor, Matthew, Spigel, David, Wang, Ding, Grote, Hans Juergen, Zhou, Dongli, Munshi, Neru, Bajars, Marcis, Gulley, James L
Publicado 2020